Role of metallothionein-III following central nervous system damage
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 13 (1) , 22-36
- https://doi.org/10.1016/s0969-9961(03)00015-9
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Cytokines and acute neurodegenerationNature Reviews Neuroscience, 2001
- Altered Central Nervous System Cytokine-Growth Factor Expression Profiles and Angiogenesis in Metallothionein-I+II Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Regulation of Growth Inhibitory Factor Expression by Epidermal Growth Factor and Interleukin‐1β in Cultured Rat AstrocytesJournal of Neurochemistry, 1999
- Localization of Metallothionein-I and -III Expression in the CNS of Transgenic Mice with Astrocyte-Targeted Expression of Interleukin 6Experimental Neurology, 1998
- Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds — an immunocytochemical study using confocal laser scan microscopeBrain Research, 1996
- Cytokines in inflammatory brain lesions: helpful and harmfulTrends in Neurosciences, 1996
- Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)Brain Research, 1994
- Development of a Competitive Double Antibody Radioimmunoassay for Rat MetallothioneinJournal of Immunoassay, 1993
- A radical hypothesis for neurodegenerationTrends in Neurosciences, 1993
- The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like proteinNeuron, 1991